Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,375 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Linked Color Imaging Focused on Neoplasm Detection in the Upper Gastrointestinal Tract : A Randomized Trial.
Ono S, Kawada K, Dohi O, Kitamura S, Koike T, Hori S, Kanzaki H, Murao T, Yagi N, Sasaki F, Hashiguchi K, Oka S, Katada K, Shimoda R, Mizukami K, Suehiro M, Takeuchi T, Katsuki S, Tsuda M, Naito Y, Kawano T, Haruma K, Ishikawa H, Mori K, Kato M; LCI-FIND Trial Group. Ono S, et al. Among authors: mori k. Ann Intern Med. 2021 Jan;174(1):18-24. doi: 10.7326/M19-2561. Epub 2020 Oct 20. Ann Intern Med. 2021. PMID: 33076693 Clinical Trial.
Diagnostic ability of linked color imaging in ultraslim endoscopy to identify neoplastic lesions in the upper gastrointestinal tract.
Haruma K, Kato M, Kawada K, Murao T, Ono S, Suehiro M, Hori S, Sasaki F, Koike T, Kitamura S, Dohi O, Kanzaki H, Yagi N, Hashiguchi K, Oka S, Katada K, Shimoda R, Mizukami K, Takeuchi T, Katsuki S, Tsuda M, Naito Y, Kawano T, Mori K, Ishikawa H. Haruma K, et al. Among authors: mori k. Endosc Int Open. 2022 Jan 14;10(1):E88-E95. doi: 10.1055/a-1723-2635. eCollection 2022 Jan. Endosc Int Open. 2022. PMID: 35047338 Free PMC article.
Linked color imaging provides enhanced visibility with a high color difference in upper gastrointestinal neoplasms.
Dohi O, Ono S, Kawada K, Kitamura S, Hatta W, Hori S, Kanzaki H, Murao T, Yagi N, Sasaki F, Hashiguchi K, Oka S, Katada K, Shimoda R, Mizukami K, Suehiro M, Takeuchi T, Katsuki S, Tsuda M, Naito Y, Kawano T, Haruma K, Ishikawa H, Mori K, Kato M; LCI-FIND TRIAL Group. Dohi O, et al. Among authors: mori k. J Gastroenterol Hepatol. 2023 Jan;38(1):79-86. doi: 10.1111/jgh.16018. Epub 2022 Oct 13. J Gastroenterol Hepatol. 2023. PMID: 36184994 Clinical Trial.
Evaluating the usefulness of considering the size and morphological type of type B2 vessel area based on Japan Esophageal Society classification in estimating tumor invasion depth in superficial esophageal squamous cell carcinomas: study protocol for a prospective observational study (Japan BEES study).
Yoshida M, Mori K, Urabe Y, Hirasawa D, Sasaki F, Takeuchi M, Kadota T, Yoshio T, Yoshinaga S, Kitamura Y, Ohno K, Ono Y, Igarashi K, Takahashi H, Ishihara R. Yoshida M, et al. Among authors: mori k. BMC Gastroenterol. 2024 Jan 26;24(1):50. doi: 10.1186/s12876-024-03138-6. BMC Gastroenterol. 2024. PMID: 38279144 Free PMC article.
Immunological and Preventive Effects of Hochuekkito and Kakkonto Against Coronavirus Disease in Healthcare Workers: A Retrospective Observational Study.
Ogawa-Ochiai K, Ishikawa H, Li H, Vu Quang L, Kimoto I, Takamura M, Hongawa T, Hane Y, Suzuki S, Okajima M, Mori K, Ito M, Takami A. Ogawa-Ochiai K, et al. Among authors: mori k. Front Pharmacol. 2021 Nov 18;12:766402. doi: 10.3389/fphar.2021.766402. eCollection 2021. Front Pharmacol. 2021. PMID: 34867392 Free PMC article.
A Novel Risk Model for Predicting Dysphagia after Tongue Reconstruction: A Retrospective Multicenter Study in Japan.
Araki J, Mori K, Yasunaga Y, Onitsuka T, Yurikusa T, Sakuraba M, Higashino T, Hashikawa K, Ishida K, Sarukawa S, Hamahata A, Kimata Y, Matsumoto H, Terao Y, Yokogawa H, Sekido M, Asato H, Miyamoto S, Hyodo I, Nakagawa M; OPERA Study Group. Araki J, et al. Among authors: mori k. Plast Reconstr Surg. 2023 Oct 1;152(4):693e-706e. doi: 10.1097/PRS.0000000000010428. Epub 2023 Mar 21. Plast Reconstr Surg. 2023. PMID: 36942956
Study Design and Rationale for Marble Study: A Phase II Trial of Atezolizumab (MPDL3280A) Plus Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Thymic Carcinoma (JTD2101).
Asao T, Shukuya T, Mimori T, Goto Y, Tanaka H, Takayama K, Tsubata Y, Tachihara M, Suzuki T, Kaira K, Ko R, Zenke Y, Akamatsu H, Tanizaki J, Ikeda S, Sugawara S, Mizutani H, Mori K, Takahashi K. Asao T, et al. Among authors: mori k. Clin Lung Cancer. 2023 Nov;24(7):e247-e253. doi: 10.1016/j.cllc.2023.05.004. Epub 2023 May 19. Clin Lung Cancer. 2023. PMID: 37316381 Clinical Trial.
7,375 results